Clinical Centre of Vojvodina Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2010
NCT01972620
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Clinical Center of Vojvodina

Active Ingredients

Drugs in Phase 4 Trials (1)

hyaluronic acid (1 trial)

Drugs in Other Trials (1)

levobupivacaine (chirocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2